期刊文献+

脑钠肽在急性肾功能衰竭患者CRRT治疗中的变化 被引量:3

The value of the B-type natriuretic peptide in patients with acute renal failure during CRRT
下载PDF
导出
摘要 目的探讨血清B型脑钠肽(B-type natriuretic peptide,BNP)和净脱水量在急性肾衰竭患者持续性肾脏替代治疗(continous renal replacement therapy,CRRT)中的变化。方法选择5例于四川大学华西医院行CRRT治疗超过24h的少尿型急性肾衰竭患者,采用ELISA方法测定0、4、8、12和24h的血清及超滤液BNP水平,运用Person分析对血清BNP降低值和净脱水量进行相关性分析。结果血清BNP呈时间依赖性下降(P<0.05);随着净脱水量增加,血清BNP的下降相应增加(r=0.798,P<0.01);超滤液BNP水平极低,且差异无统计学意义(P>0.05)。结论少尿型急性肾衰竭患者进行CRRT治疗后的容量负荷有所减轻,血清BNP显著下降;血清BNP的下降与净脱水量成正相关;BNP可从滤液中滤出,但浓度极低。 Obstructive The purpose of the study is to investigate the relationship between the serum B-type natriuretic peptide(BNP) level and the net amount of dehydration in patients with acute renal failure who were undergoing CRRT.Methods 5 patients with oliguric acute renal failure were included in the study.All patients were undergoing CRRT longer than 24 hours.The serum BNP and ultrafiltration fluid in patients at the time of 0,4,8,12 and 24h during the CRRT were measured with ELISA.The correlation between the decreased level of serum BNP and ultrafiltration volumes was analyzed with Person's linear correlation analysis.Results The serum BNP level was decreased gradually during the CRRT.The level of serum BNP at 24h significantly decreased compared with that at 0h(P0.05).The decreased level of serum BNP was dramatically correlated to the ultrafiltration volume(r=0.698,P0.01).Conclusion After CRRT,the volume load of patients with oliguric acute renal failure decreased to a certain extent and the level of serum BNP were decreased dramatically.The decreased level of serum BNP had the positive correlation with the increased ultrafiltration volume.
出处 《西部医学》 2011年第2期268-270,共3页 Medical Journal of West China
关键词 B型脑钠肽 净脱水量 持续性肾脏替代治疗 急性肾衰竭 超滤液 BNP Net amount of dehydration CRRT Acute renal failure Ultrafiltration fluid
  • 相关文献

参考文献12

  • 1王凉,孙铸兴.BNP在终末期肾病透析患者中心功能的诊断价值[J].中国血液净化,2004,3(5):276-278. 被引量:8
  • 2Jaroslav R, Hana K, Ladislav T, et al. Brain Natriuretic Pep- tide and N-Terminal proBNP in Chronic Haemodialysis Patients [J]. Nephron Clin Pract, 2006, 103(4): 162-172.
  • 3Cagatay TM, Ozkan U, Yuksel A, et al. Brain Natriuretic Peptide and Its Relationship to Left Ventricular Hypertrophy in Patients on Peritoneal Dialysis or Hemodialysis Less Than 3 Years [J]. Renal Failure, 2006, 28(2) : 133-139.
  • 4Zeng C, Wei T, Jin L, et al. Value of B-type natriuretic peptide in diagnosing left ventricular dysfunction in dialysis-dependent patients[J]. Internal Medicine Journal, 2006,36 (9) : 552-557.
  • 5Martin B, Antonin J, Miehal K, et al. Relationship between Natriuretie Peptides and Residual Diuresis during Continuous Hemodiafiltration[J]. Blood Purif, 2003, 21(6): 401-408.
  • 6Omland T. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptldes in evaluation of acute heart failure[J]. Crit Care Med, 2008, 36(1):S17-27.
  • 7Bargnoux AS, Klouche K, Fareh J, et al. Prohormone brain natriuretic peptide (proBNP), BNP and N-terminal-proBNP circulating levels in chronic hemodialysis patients. Correlation with ventricular function, fluid removal and effect of hemodiafiltration[J]. Clin Chem Lab Med, 2008, 46(7):1019-1024.
  • 8Haapio M, Roneo C. BNP and a renal patient: emphasis on the unique characteristics of B-type natriuretie peptide in end-stage kidney disease[J]. Contrib Nephrol, 2008, 161: 68-75.
  • 9Chandra A, Otero R, Freeman D, et al. BNP-mediated vasodilatation for dialysis-dependent patient with acute heart failure syndrome in the emergency department[J]. Ren Fail, 2008, 30 (1): 45-50.
  • 10Bavbek N, Akay H, Altay M, et al. Serum BNP concentration and left ventricular mass in CAPD and automated peritoneal dialysis patients[J]. Perit Dial Int, 2007, 27(6):663-668.

二级参考文献25

  • 1[1]Wilkins MR, Redondo J, Brown LA. The natriuretic peptide family.Lancet, 1997,349 : 1307 - 1310
  • 2[2]Luchner A, Stevens TL, Borgeson DD, et al. Different atrial and ventriculur expression of myocardial BNP during evolution of heart failure.46th Annual Scientific Session of America College of Cardiology, 1998,H1684 - H1689
  • 3[3]Mair J, Lercher AH, Puschendort B. The impact of cardiac natriuretic peptides determination on the diagnosis and management of heart failure.Clin Chem Lab, 2001,39(7) 571 -588
  • 4[4]Stingo AJ, Clavell AL, Heublein DM, et al. Presence ofC - type natriuretic peptides in cultured human endothelial cells and plasma. Am J Physiol, 1992, 235:561 - 576
  • 5[5]Zoccali C, Mallamaci F, Benedetto FA, et al. Cardiac natriuretic peptide are related to left ventricular mass and function and predict mortality in dialysis patients. J Am Soc Nephrol, 2001,12:1508- 1515
  • 6[6]Kohs KP, Feifel K, Mayer Wehrstain R. Differential regulation of brain and atrial natriuretic peptides in hemodialysis patients. Clin Nephrol,1993,40:83 - 90
  • 7[7]McDonagh TA, Morrison CE, Lawrence A, et al. Symptomatic and asymptonmatic left vantricular systolic dysfunction in an urban population.Lancet, 1997, 350: 829 - 833
  • 8[8]Francis GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substady of the studies of left veatricular dysfunction (SOLVD). Circulation, 1990, 82:1724 - 1729
  • 9[9]Struthers. Prospects for using a blood sample in the diagnosis of heart failure Q J Med, 1995, 88:303 - 306
  • 10[10]Maeda K, Tsutamoto T, Wada A, et al. High levels of plasma brain natriuretic peptide and interleukin - 6 after optimized treatment for heart failure arc independent risk factors for morbidity and mortality in patients with congestive heart failure. J Am Coil Cardiol, 2000,36:1587- 93

共引文献7

同被引文献15

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部